1 Norhammar A, Tenerz A, Nilsson G, et al.: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359 (9324): 2140- 2144.
2 Bartnik M, Rydén L, Ferrari R, et al.: The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25 (21):1880-1890.
3 Hu DY, Pan CY, Yu JM: The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J 2006; 27 (21): 2573-2579.
4 Tamita K, Katayama M, Takagi T, et al.: Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction. Circ J 2007; 71(6): 834-841.
5 Bartnik M, Malmberg K, Norhammar A, et al.: Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004; 25: 1990-1997.
6 Matz K, Keresztes K, Tatschl C, et al.: Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes care 2006; 29(4): 792 - 797.
7 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 Suppl 1: S62-69.
8 WHO Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated Report of a WHO Consultation. World Health Organization. Geneva 2011
9 Matz K, Teuschl Y, Firlinger B, et al.: ASPIS Study Group. Multidomain lifestyle interventions for the prevention of cognitive cecline after ischemic stroke: a randomized trial. Stroke 2015; 46: 2874-2880.
10 World Health Organization: Definition, iagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999.
11 Jia Q, Zheng H, Zhao X, et al.; Investigators for the Survey on Abnormal Glucose Regulation in Patients With Acute Stroke Across China (ACROSS-China). Abnormal glucose regulation in patients with acute stroke across China: prevalence and baseline patient characteristics. Stroke 2012; 43: 650-657.
12 Vancheri F, Curcio M, Burgio A, et al.: Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. QJM. 2005; 98(12): 871-878.
13 Wu S, Shi Y, Pan Y, Li J, et al.: Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study. BMC Neurol 2014, 12; 14: 177.
14 Zhang X, Shi Q, Zheng H, et al.: Prevalence of abnormal glucose regulation according to different diagnostic driteria in ischaemic Ssroke without a history of diabetes. Biomed Res Int 2018, 8358724
15 Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344(18): 1343-1350.
16 Knowler WC, Barrett-Connor E, Fowler SE, et al. ; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346(6): 393-403.
17 Chiasson JL, Josse RG, Gomis R, et al. ; STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002; 359(9323): 2072-2077.
18 Kernan WN, Viscoli CM, Furie KL, et al. ; IRIS Trial Investigators. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med 2016; 374(14): 1321-1331.
19 le Roux CW, Astrup A, Fujioka K, et al. ; SCALE Obesity Prediabetes NN8022-1839 Study Group. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet 2017; 389(10077): 1399-1409.
20 Lee M, Saver JL, Liao HW, Lin CH,et al.:. Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis. Stroke 2017; 48: 388-393.
21 Shahim B, Gyberg V, De Bacquer D, et al.: Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology. Cardiovasc Diabetol 2018; 24; 17: 21.
22 Dorr R, Stumpf J, Spitzer SG, et al.: [Prevalence of undetected diabetes mellitus in invasive and interventional cardiology. Silent diabetes in the catheterization laboratory]. Herz 2012; 37(3): 244-250.
23 Qiao Q, Pyorala K, Pyorala M, et al.: Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. European heart journal 2002; 23 (16): 1267-1275.
24 DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Archives of internal medicine 2001; 161(3): 397-405.
25 Temelkova-Kurktschiev TS, Koehler C, et al.: Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000; 23(12): 1830-1834.
26 Foreman YD, Brouwers MCGJ, et al.: The oral glucose tolerance test-derived incremental glucose peak is associated with greater arterial stiffness and maladaptive arterial remodeling: The Maastricht Study. Cardiovasc Diabetol 2019; 14;18 :152.
27 DECODE Study Group, European Diabetes Epidemiology Group.Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes care 2003; 26(3): 688-696.
28 Qiao Q, Dekker JM, de Vegt F, et al.: Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c. Journal of clinical epidemiology 2004; 57(6): 590-596.
29 Meigs JB, Nathan DM, D’Agostino RB Sr et al.; Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25: 1845–1850
30 Shahim B, De Bacquer D, De Backer G, et al.: The prognostic value of fasting plasma glucose, two-hour postload glucose, and HbA1c in patients with coronary artery disease: A report from EUROASPIRE IV: A Survey from the European Society of Cardiology. Diabetes Care 2017; 40(9): 1233-1240.
31 Jing J, Pan Y, Zhao X, et al. Prognosis of ischemic stroke with newly diagnosed diabetes mellitus according to hemoglobin A1c criteria in Chinese population. Stroke 2016; 47: 2038-2044.
32 Capes SE, Hunt D, Malmberg K, et al.: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426–2432.
33 Osei E, den Hertog HM, Fonville S, et al.: Prediction of persistent impaired glucose tolerance in patients with minor ischemic stroke or transient ischemic attack. J Stroke Cerebrovasc Dis 2020; 29(6): 104815.